FDA warns firms for CGMP, QSR violations; online retailers cited for selling unapproved drugs
Regulatory NewsFerdous Al-Faruque
APIsMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters